333 related articles for article (PubMed ID: 15747240)
1. Administration of protein-conjugate pneumococcal vaccine to patients who have invasive disease after splenectomy despite their having received 23-valent pneumococcal polysaccharide vaccine.
Musher DM; Ceasar H; Kojic EM; Musher BL; Gathe JC; Romero-Steiner S; White AC
J Infect Dis; 2005 Apr; 191(7):1063-7. PubMed ID: 15747240
[TBL] [Abstract][Full Text] [Related]
2. The 23-valent pneumococcal polysaccharide vaccine does not provide additional serotype antibody protection in children who have been primed with two doses of heptavalent pneumococcal conjugate vaccine.
Balmer P; Borrow R; Arkwright PD
Vaccine; 2007 Aug; 25(34):6321-5. PubMed ID: 17629373
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy.
Abzug MJ; Pelton SI; Song LY; Fenton T; Levin MJ; Nachman SA; Borkowsky W; Rosenblatt HM; Marcinak JF; Dieudonne A; Abrams EJ; Pathak I;
Pediatr Infect Dis J; 2006 Oct; 25(10):920-9. PubMed ID: 17006288
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of sequential pneumococcal vaccination in subjects splenectomised for hereditary spherocytosis.
Stoehr GA; Rose MA; Eber SW; Heidemann K; Schubert R; Zielen S
Br J Haematol; 2006 Mar; 132(6):788-90. PubMed ID: 16487181
[TBL] [Abstract][Full Text] [Related]
6. Safety and immunogenicity of the American Academy of Pediatrics--recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipients.
Lin PL; Michaels MG; Green M; Mazariegos GV; Webber SA; Lawrence KS; Iurlano K; Greenberg DP
Pediatrics; 2005 Jul; 116(1):160-7. PubMed ID: 15995047
[TBL] [Abstract][Full Text] [Related]
7. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
[TBL] [Abstract][Full Text] [Related]
8. Total and serotype-specific pneumococcal antibody titres in children with normal and abnormal humoral immunity.
Uddin S; Borrow R; Haeney MR; Moran A; Warrington R; Balmer P; Arkwright PD
Vaccine; 2006 Jul; 24(27-28):5637-44. PubMed ID: 16730399
[TBL] [Abstract][Full Text] [Related]
9. Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory.
de Roux A; Schmöle-Thoma B; Siber GR; Hackell JG; Kuhnke A; Ahlers N; Baker SA; Razmpour A; Emini EA; Fernsten PD; Gruber WC; Lockhart S; Burkhardt O; Welte T; Lode HM
Clin Infect Dis; 2008 Apr; 46(7):1015-23. PubMed ID: 18444818
[TBL] [Abstract][Full Text] [Related]
10. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.
Pletz MW; Maus U; Krug N; Welte T; Lode H
Int J Antimicrob Agents; 2008 Sep; 32(3):199-206. PubMed ID: 18378430
[TBL] [Abstract][Full Text] [Related]
11. Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies.
Siber GR; Chang I; Baker S; Fernsten P; O'Brien KL; Santosham M; Klugman KP; Madhi SA; Paradiso P; Kohberger R
Vaccine; 2007 May; 25(19):3816-26. PubMed ID: 17368878
[TBL] [Abstract][Full Text] [Related]
12. Functional antibodies elicited by two heptavalent pneumococcal conjugate vaccines in the Finnish Otitis Media Vaccine Trial.
Ekström N; Väkeväinen M; Verho J; Kilpi T; Käyhty H
Infect Immun; 2007 Apr; 75(4):1794-800. PubMed ID: 17261612
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and safety of a pneumococcal conjugate 7-valent vaccine in infants with sickle cell disease.
Reinert P; Benkerrou M; de Montalembert M; Lesprit E; Abadie I; Bernaudin F; Doit C; Bingen E; Tetelboum R; Bonnet E
Pediatr Infect Dis J; 2007 Dec; 26(12):1105-9. PubMed ID: 18043446
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of pneumococcal vaccination of patients with cochlear implants.
Rose M; Hey C; Kujumdshiev S; Gall V; Schubert R; Zielen S
J Infect Dis; 2004 Aug; 190(3):551-7. PubMed ID: 15243931
[TBL] [Abstract][Full Text] [Related]
15. A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma.
Landgren O; Björkholm M; Konradsen HB; Söderqvist M; Nilsson B; Gustavsson A; Axdorph U; Kalin M; Grimfors G
J Intern Med; 2004 Jun; 255(6):664-73. PubMed ID: 15147530
[TBL] [Abstract][Full Text] [Related]
16. A case-control study to investigate serological correlates of clinical failure of 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults.
French N; Moore M; Haikala R; Kayhty H; Gilks CF
J Infect Dis; 2004 Aug; 190(4):707-12. PubMed ID: 15272398
[TBL] [Abstract][Full Text] [Related]
17. Selective defect of anti-pneumococcal IgG in a patient with persistent polyclonal B cell lymphocytosis.
Hafraoui K; Moutschen M; Smet J; Mascart F; Schaaf-Lafontaine N; Fillet G
Eur J Intern Med; 2009 May; 20(3):e62-5. PubMed ID: 19393481
[TBL] [Abstract][Full Text] [Related]
18. The effect of 23-valent pneumococcal polysaccharide vaccine on immunological priming induced by 7-valent conjugate vaccine in asplenic subjects with beta-thalassemia.
Orthopoulos GV; Theodoridou MC; Ladis VA; Tsousis DK; Spoulou VI
Vaccine; 2009 Jan; 27(3):350-4. PubMed ID: 19010369
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of CRM₁₉₇ conjugated 9-valent pneumococcal and meningococcal C combination vaccine in healthy infants.
Mallet E; Brachet E; Fernsten P; Laudat F; Razmpour A; Gruber WC;
Vaccine; 2011 Aug; 29(34):5812-9. PubMed ID: 21296118
[TBL] [Abstract][Full Text] [Related]
20. Pneumococcal bacteremia among infants with fever without known source before and after introduction of pneumococcal conjugate vaccine in the Basque Country of Spain.
Benito-Fernández J; Raso SM; Pocheville-Gurutzeta I; SánchezEtxaniz J; Azcunaga-Santibañez B; Capapé-Zache S
Pediatr Infect Dis J; 2007 Aug; 26(8):667-71. PubMed ID: 17848875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
